Publications by authors named "Felicity Lose"

Are you Felicity Lose?   Register this Author

Association between single-nucleotide polymorphisms in growth factor genes and quality of life in men with prostate cancer and the general population.
Qual Life Res 2015 Sep 28;24(9):2183-93. Epub 2015 Feb 28.
Institute of Health and Biomedical Innovation (IHBI), School of Nursing, Queensland University of Technology (QUT), Kelvin Grove, Brisbane, QLD, 4059, Australia,

Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk.
Hum Mol Genet 2015 Mar 6;24(5):1478-92. Epub 2014 Nov 6.
QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia,


Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk.
Hum Genet 2015 Feb 9;134(2):231-45. Epub 2014 Dec 9.
Genome Center and Department of Biochemistry and Molecular Medicine, School of Medicine, University of California, Davis, CA, 95616, USA,

Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.
Cancer Epidemiol Biomarkers Prev 2015 Jan 21;24(1):308-16. Epub 2014 Oct 21.
Sheba Medical Center, Tel Aviv, Israel.


Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing.
J Clin Oncol 2014 Jan 9;32(2):90-100. Epub 2013 Dec 9.
Daniel D. Buchanan, Yen Y. Tan, Michael D. Walsh, Mark Clendenning, Alexander M. Metcalf, Kaltin Ferguson, Sven T. Arnold, Bryony A. Thompson, Felicity A. Lose, Michael T. Parsons, Rhiannon J. Walters, Sally-Ann Pearson, Joanne P. Young, Penelope M. Webb, and Amanda B. Spurdle, QIMR Berghofer Medical Research Institute, Herston; Yen Y. Tan and Andreas Obermair, University of Queensland School of Medicine, Brisbane; Margaret Cummings, University of Queensland Centre for Clinical Research, Herston, Queensland; Martin K. Oehler, Royal Adelaide Hospital, Adelaide, South Australia; Michael A. Quinn, Royal Women's Hospital, Melbourne, Victoria; Judy A. Kirk, Westmead Institute for Cancer Research, Westmead Millennium Institute, University of Sydney, Sydney, New South Wales; Colin J. Stewart, King Edward Memorial Hospital, Perth, Western Australia, Australia; and Penelope B. Blomfield, Royal Hobart Hospital, Hobart, Tasmania.


Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.
Nat Genet 2013 Apr;45(4):385-91, 391e1-2
The Institute of Cancer Research, Sutton, UK.


A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.
Hum Mol Genet 2013 Jan 12;22(2):408-15. Epub 2012 Oct 12.
Strangeways Laboratory, Centre for Cancer Genetic Epidemiology, Worts Causeway, Cambridge CB1 8RN, UK.



A replication study examining novel common single nucleotide polymorphisms identified through a prostate cancer genome-wide association study in a Japanese population.
Am J Epidemiol 2011 Dec 15;174(12):1391-5. Epub 2011 Nov 15.
Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Brisbane, Queensland 4059, Australia.

Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.
Nat Genet 2011 Jul 10;43(8):785-91. Epub 2011 Jul 10.
The Institute of Cancer Research, Sutton, Surrey, UK.

A Kallikrein 15 (KLK15) single nucleotide polymorphism located close to a novel exon shows evidence of association with poor ovarian cancer survival.
BMC Cancer 2011 Apr 1;11:119. Epub 2011 Apr 1.
Australian Prostate Cancer Research centre-Queensland and Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Brisbane, Queensland 4059, Australia.

Vascular endothelial growth factor gene polymorphisms and ovarian cancer survival.
Gynecol Oncol 2010 Dec 15;119(3):479-83. Epub 2010 Sep 15.
Molecular Cancer Epidemiology, Queensland Institute of Medical Research, P.O. Royal Brisbane Hospital, Herston, Brisbane, QLD 4029, Australia.

Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.
Nat Genet 2009 Oct 20;41(10):1116-21. Epub 2009 Sep 20.
The Institute of Cancer Research, Sutton, Surrey, UK.

The RAD51D E233G variant and breast cancer risk: population-based and clinic-based family studies of Australian women.
Breast Cancer Res Treat 2008 Nov 4;112(1):35-9. Epub 2007 Dec 4.
Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, University of Melbourne, Victoria, Australia.


OF